Our approach, which demonstrates long‐lasting gene expression in the Ush1c KO mouse model, suggests that similar strategies could enhance gene therapies for a range of genetic disorders, ultimately providing substantial benefits to affected patients. This evidence concerns the gene USH1C and hereditary disease.